A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans

Journal of Infectious Diseases

Volumn 199, Issue 5, 2009, Pages 684-692

  Bauer, Margaret E ^a,b   Townsend, Carisa A ^a   Doster, Ryan S ^a   Fortney, Kate R ^a   Zwickl, Beth W ^a   Katz, Barry P ^a   Spinola, Stanley M ^a   Janowicz, Diane M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 635 Barnhill Dr ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; LIPOPROTEIN; MUTANT PROTEIN; OLIGONUCLEOTIDE; PROTEIN FIBRINOGEN BINDER A; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; HAEMOPHILUS DUCREYI; HUMAN; INOCULATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TANDEM MASS SPECTROMETRY; ULCUS MOLLE;

ADULT; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CHANCROID; FEMALE; FIBRINOGEN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HAEMOPHILUS DUCREYI; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; SKIN DISEASES, BACTERIAL; VIRULENCE; YOUNG ADULT;

EID: 61849155746     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/596656     Document Type: Article

References (45)

1. Steen R. On eradicating chancroid. Bull WHO 2001; 79:818-26.
2. Spinola SM, Bauer ME, Munson RS Jr. Immunopathogenesis of Haemophilus ducreyi infection (chancroid). Infect Immun 2002; 70:1667-76.
3. Bauer ME, Spinola SM. Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection. Infect Immun 2000; 68:2309-14.
4. Bauer ME, Goheen MP, Townsend CA, Spinola SM. Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers. Infect Immun 2001; 69:2549-57.
5. Bauer ME, Townsend CA, Ronald AR, Spinola SM. Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. Microbes Infect 2006; 8:2465-8.
6. Fulcher RA, Cole LE, Janowicz DM, et al. Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid. Infect Immun 2006; 74:2651-8.
7. Janowicz DM, Fortney KR, Katz BP, et al. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers. Infect Immun 2004; 72:4528-33.
8. Bong CTH, Throm RE, Fortney KR, et al. A DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers. Infect Immun 2001; 69:1488-91.
9. Janowicz DM, Leduc I, Fortney KR, Katz BP, Elkins C, Spinola SM. A DltA mutant of Haemophilus ducreyi is partially attenuated in its ability to cause pustules in human volunteers. Infect Immun 2006; 74:1394-7.
10. Al-Tawfiq JA, Fortney KR, Katz BP, Elkins C, Spinola SM. An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection. J Infect Dis 2000; 181:1049-54.
11. Fortney KR, Young RS, Bauer ME, et al. Expression of peptidoglycan- associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection. Infect Immun 2000; 68:6441-8.
12. Spinola SM, Fortney KR, Katz BP, et al. Haemophilus ducreyi requires an intact flp gene cluster for virulence in humans. Infect Immun 2003; 71:7178-82.
13. Banks KE, Fortney KR, Baker B, et al. The enterobacterial common antigen-like gene cluster of Haemophilus ducreyi contributes to virulence in humans. J Infect Dis 2008; 197:1531-6.
14. Bauer ME, Fortney KR, Harrison A, Janowicz DM, Munson RS Jr, Spinola SM. Identification of Haemophilus ducreyi genes expressed during human infection. Microbiology 2008; 154:1152-60.
15. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004; 340:783-95.
16. Gardy JL, Laird MR, Chen F, et al. PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 2005; 21:617-23.
17. Gennity JM, Inouye M. The protein sequence responsible for lipoprotein membrane localization in Escherichia coli exhibits remarkable specificity. J Biol Chem 1991; 266:16458-64.
18. Letunic I, Copley RR, Pils B, Pinkert S, Schultz J, Bork P. SMART 5: domains in the context of genomes and networks. Nucleic Acids Res 2006; 34:D257-D260.
19. Terada M, Kuroda T, Matsuyama S, Tokuda H. Lipoprotein sorting signals evaluated as the LolA-dependent release of lipoproteins from the cytoplasmic membrane of Escherichia coli. J Biol Chem 2001; 276:47690-4.
20. Yamaguchi K, Yu F, Inouye M. A single amino acid determinant of the membrane localization of lipoproteins in E. coli. Cell 1988; 53:423-32.
21. Al-Tawfiq JA, Thornton AC, Katz BP, et al. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis 1998; 178:1684-7.
22. Hammond GW, Lian CJ, Wilt JC, Ronald AR. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother 1978; 13:608-12.
23. Spinola SM, Griffiths GE, Bogdan JA, Menegus MA. Characterization of an 18,000 molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope. Infect Immun 1992; 60:385-91.
24. White CD, Leduc I, Olsen B, Jeter C, Harris C, Elkins C. Haemophilus ducreyi outer membrane determinants, including DsrA, define two clonal populations. Infect Immun 2005; 73:2387-99.
25. Deneer HG, Slaney L, Maclean IW, Albritton WL. Mobilization of non-conjugative antibiotic resistance plasmids in Haemophilus ducreyi. J Bacteriol 1982; 149:726-32.
26. Post DM, Gibson BW. Proposed second class of Haemophilus ducreyi strains show altered protein and lipooligosaccharide profiles. Proteomics 2007; 7:3131-42.
27. Hiltke TJ, Bauer ME, Klesney-Tait J, Hansen EJ, Munson RS Jr, Spinola SM. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants. Microb Pathog 1999; 26:93-102.
28. McDevitt D, Nanavaty T, House-Pompeo K, et al. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem 1997; 247:416-24.
29. Menard R, Sansonetti PJ, Parsot C. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J Bacteriol 1993; 175:5899-906.
30. Bozue JA, Tarantino L, Munson RS Jr. Facile construction of mutations in Haemophilus ducreyi using lacz as a counter-selectable marker. FEMS Microbiology Letters 1998; 164:269-73.
31. Wood GE, Dutro SM, Totten PA. Target cell range of Haemophilus ducreyi hemolysin and its involvement in invasion of human epithelial cells. Infect Immun 1999; 67:3740-9.
32. Crother TR, Champion CI, Wu X-Y, Blanco DR, Miller JN, Lovett MA. Antigenic composition of Borrelia burgdorferi during infection of SCID mice. Infect Immun 2003; 71:3419-28.
33. Decker ED, Zhang Y, Cocklin RR, Witzmann FA, Wang M. Proteomic analysis of differential protein expression induced by ultraviolet light radiation in HeLa cells. Proteomics 2003; 3:2019-27.
34. Brown DPG, Gökmen-Polar Y, Jiang L, et al. A comparative proteomic study to characterize the vinblastine resistance in human ovarian cancer cells. Proteomics Clin Appl 2007; 1:18-31.
35. Delahay RM, Frankel G. Coiled-coil proteins associated with type III secretion systems: a versatile domain revisited. Mol Microbiol 2002; 45:905-16.
36. Hovis KM, Freedman JC, Zhang H, Forbes JL, Marconi RT. Identification of an antiparallel coiled-coil/loop domain required for ligand binding by the Borrelia hermsii FgbA protein: additional evidence for the role of FhbA in the host-pathogen interaction. Infect Immun 2008; 76:2113-22.
37. McNamara C, Zinkernagel AS, Macheboeuf P, Cunningham MW, Nizet V, Ghosh P. Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science 2008; 319:1405-8.
38. Meehan M, Muldowney DA, Watkins NJ, Owen P. Localization and characterization of the ligand-binding domain of the fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi. Microbiology 2000; 146:1187-94.
39. Ringdahl U, Svensson HG, Kotarsky H, Gustafsson M, Weineisen M, Sjobring U. A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol 2000; 37:1318-26.
40. Schubert A, Zakikhany K, Schreiner M, et al. A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites. Mol Microbiol 2002; 46:557-69.
41. Celli J, Finlay BB. Bacterial avoidance of phagocytosis. Trends Microbiol 2002; 10:232-7.
42. Whitnack E, Beachey EH. Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest 1982; 69:1042-5.
43. Whitnack E, Beachey EH. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med 1985; 162:1983-97.
44. Boschwitz JS, Timoney JF. Characterization of the antiphagocytic activity of equine fibrinogen for Streptococcus equi subsp. equi. Microb Pathog 1994; 17:121-9.
45. Campo RE, Schultz DR, Bisno AL. M proteins of group G streptococci: mechanisms of resistance to phagocytosis. J Infect Dis 1995; 171:601-6.